Novel bicyclic nucleosides and oligomers prepared therefrom
US-2019345188-A1 · Nov 14, 2019 · US
attached in position 6, e.g. hypoxanthine
attached in position 6, e.g. hypoxanthine · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D473/30 |
| Official title | attached in position 6, e.g. hypoxanthine |
| Display label | attached in position 6, e.g. hypoxanthine |
| Total patents | 114 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 14 |
| 2016 | 8 |
| 2017 | 15 |
| 2018 | 11 |
| 2019 | 13 |
| 2020 | 15 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Fused hetero-hetero bicyclic compounds and methods of use thereof
US-2019345158-A1 · Nov 14, 2019 · US
Oxadiazole transient receptor potential channel inhibitors
US-2019284179-A1 · Sep 19, 2019 · US
Alternative nucleic acid molecules and uses thereof
US-2019255194-A1 · Aug 22, 2019 · US
Respiratory formulations and compounds for use therein
US-10358445-B2 · Jul 23, 2019 · US
Enantiomers of the 1',6'-isomer of neplanocin a
US-2019202854-A1 · Jul 4, 2019 · US
Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors
US-2019144446-A1 · May 16, 2019 · US
Alternative nucleic acid molecules and uses thereof
US-10286086-B2 · May 14, 2019 · US
Enantiomers of the 1′,6′-isomer of neplanocin A
US-10227373-B2 · Mar 12, 2019 · US
Purine inhibitors of human phosphatidylinositol 3-kinase delta
US-10221178-B2 · Mar 5, 2019 · US
Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors
US-10208038-B2 · Feb 19, 2019 · US
Fused tricyclic compounds as raf kinase inhibitors
US-2019000857-A1 · Jan 3, 2019 · US
Purine inhibitors of human phosphatidylinositol 3-kinase delta
US-10100064-B2 · Oct 16, 2018 · US
Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors
US-2018282326-A1 · Oct 4, 2018 · US
UBA5 inhibitors
US-10077284-B2 · Sep 18, 2018 · US
Thymine derivatives and quinazoline-dione derivatives for the inhibition of hsp27
US-2018207160-A1 · Jul 26, 2018 · US
Respiratory formulations and compounds for use therein
US-2018201611-A1 · Jul 19, 2018 · US
Purine Inhibitors of Human Phosphatidylinositol 3-Kinase Delta
US-2018141947-A1 · May 24, 2018 · US
Anti-ice nucleation activator
US-2018127631-A1 · May 10, 2018 · US
Heterocyclic compounds and their uses
US-2018105532-A1 · Apr 19, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D473/30?
- CPC C07D473/30 is the Cooperative Patent Classification code for “attached in position 6, e.g. hypoxanthine.”
- How many patents are filed under CPC C07D473/30 (attached in position 6, e.g. hypoxanthine)?
- Our database includes 114 publications tagged with this CPC code.
- Is patent activity under CPC C07D473/30 growing?
- Publication counts under this code: 8 in 2024 vs 8 in 2025 (latest complete years).